Lappuse 1 no 34 rezultātiem
FIELD OF THE INVENTION
The invention relates to a probiotic and a composition comprising the same. Particularly, the invention relates to a new lactic acid bacteria and its use in enhancing immunomodulatory and anti-inflammatory activity.
BACKGROUND OF THE INVENTION
Fermented food products contain
BACKGROUND OF THE INVENTION
Lactic acid bacteria are Gram-positive bacteria that produce lactic acid by the fermentation of glucose Streptococcus thermophilus is also included in this definition by convention.
It is well known that strains of lactic acid bacteria that produce H.sub.2O.sub.2 can act
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to and the benefit of Korean Patent Application No. 10-2015-0033698 filed on Mar. 11, 2015, Korean Patent Application No. 10-2016-0029069 filed on Mar. 10, 2016 and International Patent Application No. PCT/KR2016/002473, filed
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to use of a method for screening nonpathogenic anti-inflammatory bacterial strains, and products and methods using such strains for treatment and prophylaxis of unwanted inflammation caused by certain bacteria or other
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to use of a method for screening nonpathogenic anti-inflammatory bacterial strains, and products and methods using such strains for treatment and prophylaxis of inflammation caused by gastrointestinal bacteria such as
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to use of a method for screening nonpathogenic antiinflammatory bacterial strains, and products and methods using such strains for treatment and prophylaxis of inflammation caused by gastrointestinal bacteria such as
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to use of a method for screening nonpathogenic anti-inflammatory bacterial strains, and products and methods using such strains for treatment and prophylaxis of inflammation caused by gastrointestinal bacteria such as
TECHNICAL FIELD OF THE INVENTION
This invention relates to butyrate prodrugs derived from lactic acid and pharmaceutical compositions and methods employing them, either alone or in combination with other agents, for increasing gamma globin and fetal hemoglobin in a patient. These compounds,
FIELD OF THE INVENTION
The present invention relates to pharmaceutical composition which contains active ingredients and is effective as a self-sustaining delivery mechanism for its own delivery for desired extended periods of time. More particularly, this invention relates to an injectable
TECHNICAL FIELD OF THE INVENTION
This invention relates to the use of butyrate prodrugs derived from lactic acid for treating inflammatory bowel disease. The invention also relates to the use of those prodrugs for the treatment of a chemotherapy-induced mucocutaneous side effect in a patient. The
FIELD OF THE INVENTION
The invention relates to the use of lactic acid bacteria as regulators of inflammation of the intestinal mucous membrane.
BACKGROUND OF THE INVENTION
Lactic acid bacteria are conventionally used for manufacturing fermented food products, in particular dairy products.
It has
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web in U.S. application Ser. No. 14/232,475 and is hereby incorporated by reference in its entirety. Said ASCII copy, is named "49455 704 401 SEQ.pdf and is 134,167 bytes in
FIELD OF THE INVENTION
The present invention relates to a microorganism strain that induces an immunoregulatory function, for example, lactic acid bacteria or an ingredient having an immunoregulatory function derived from a microorganism, and to a method of obtaining the lactic acid bacteria or
This application is a U.S. National Stage Application under 35 U.S.C. .sctn.371 of International Patent Application No. PCT/KR2012/004233 filed 30 May 2012, which claims the benefit of priority to Korean Patent Application No. 10-2011-0051653 filed 30 May 2011, the disclosures of all of which are
CROSS-REFERENCES TO RELATED APPLICATIONS
Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.
Technical Field
The present invention relates to